Australian Operations
   
Include All CSL Sites

Tetrabenazine

Tetrabenazine

TETRABENAZINE is used for the treatment of diseases, which cause jerky, irregular, uncontrollable movements such as Huntington's chorea, senile chorea and hemiballismus.
 
This product is available only with a doctor’s prescription.
 
Who is this information for?
 
This information is relevant in Australia and is intended for people who have been prescribed this product or health care professionals.
 
Consumer Medicine Information
 
The Consumer Medicine Information (CMI) is a leaflet written for consumers. The CMI contains information about the medicine including:
  • What this product is used for
  • How it works
  • How this product is given
  • Side effects
View the Tetrabenazine Consumer Medicine Information
 
Product Information
 
Product Information contains information to ensure the safe and effective use of a medicine. This document is approved by the Therapeutic Goods Administration and made available by Seqirus for you if you are a:
  1. qualified healthcare professional; or
  2. consumer, provided you have read the Consumer Medicine Information for the product; want further information on the product; and agree to consult with your healthcare professional if you have any questions in relation to the Product Information.
View the Tetrabenazine Product Information (PDF, 0.20MB)



Tetrabenazine is registered by iNova Pharmaceuticals (Australia) Pty Ltd and used under licence by Seqirus (Australia)Pty Ltd

Last Updated: 16-12-2015
Share
LinkedIn Twitter Facebook Google+
© 2017 Seqirus